Biotech Values

[DewDiligence]

Unless Momenta can get the Court to reconsider the case en banc, this is over.

I think that’s a slight overstatement. The ruling from the Appellate Court does not categorically preclude the District Court from holding the patent trial as scheduled, although it does make such an outcome less likely.